Wild Swing Trades 📈

Stocks Sitting Near Support: Where the Bounce Could Start The scanner is finding something interesting: a number of stocks are sitting directly on, or just above, important support levels. That does not automatically make them buys. It gives us something better — clearly defined areas where a bounce can be tested with controlled risk. The strongest setups in this scan are ABI, FBRX, BR and AU . There is also a separate cluster worth watching in precious metals, with GLD, GDX, SLV and SIL all sitting relatively close to their 40-day support areas. The key idea: I would rather buy a confirmed bounce from support than chase a stock after it has already moved several percent away from the level. Support gives us a place to define the trade before entering. The Closest Stocks to Support Asset Price Support Distance Support Scanner Score Setup ABI $24.50 $24.46 +0.2% 40-Day 94 Excellent FBRX $76.99 $76.96 ~0.0% 40-Day 78 Excellent BR $156....

11 Stocks From the Live Scanners: Where Are the Actual Trades? The scanners identified the candidates. Now we turn raw output into actionable setups. Live scanners run to identify candidates based on quantitative filters, momentum shifts, and technical support reversals. However, a stock appearing on a scanner output is not automatically a buy signal. To turn scanner candidates into execution plans, every name must be evaluated through a structured execution framework: Where would I enter, where am I wrong, where do I take profit, and is the expected reward worth the risk? Reference prices are based on the October 2, 2026 close. Entry zones represent preferred tactical levels rather than market-order executions. Probability figures are setup estimates derived from technical parameters, not guaranteed win rates. Live Scanner Results Overview The scanner process separates broad discovery from tactical evaluation. Candidates are grouped...

Quality Reversal Technical Scanner & Trade Execution Matrix Quality Reversal Technical Scanner Output The scanner identified 13 reversal candidates out of 150 tracked equities based on key moving average support proximity, RSI momentum boundaries, and pattern triggers. Symbol Score Price Support Level Distance RSI Divergence Pattern Primary Setup Status AAT 107 $21.39 s200 ($21.19) +0.9% 47 Yes (Bullish) — Top Candidate 200 SMA rebound ABM 101 $48.46 s50 ($48.36) +0.2% 42 Yes (Bullish) — Top Candidate Tight 50 SMA bounce BBY 99 $87.70 ...

Mean reversion · October 2, 2026 close The Oversold Quality Bounce is a mean-reversion sleeve, not a value-trap basket. You buy a business whose economics are still intact after the price has overshot on a narrative, a growth scare, or a sector de-rating — and only when the tape says selling is tired. Not investment advice. This is an educational write-up of a screen, not a recommendation to buy, sell, or hold any security. Prices, ratios, RSI readings, and street targets are point-in-time figures as of the October 2, 2026 close and will be stale by the time you read this. Technical levels fail. Consensus estimates get cut. You can lose money, including more than you expect on a “quality” name. Nothing here is personalized advice, a solicitation, or a promise about future returns. Do your own work, and consider whether a trade fits your risk tolerance, time horizon, and tax situation. Applied to Booking Holdings (BKNG) , Colgate-Palmolive (CL) , Adobe (ADBE) , and Chewy...

Market note · October 1, 2026 Intellia (NASDAQ: NTLA) at $12.12: Coil, Not a Breakout A levels-and-scenarios playbook for the in-vivo CRISPR name. Tape read as of the October 1, 2026 close. Disclaimer. This is market commentary, not investment advice, a solicitation, or a recommendation to buy or sell any security. Biotech is binary. A safety headline, a trial delay, or a financing can gap through any stop. Scenario probabilities are subjective weights based on price structure, volume, and public disclosures as of October 1, 2026. They are not forecasts. Intellia is pre-commercial, cash-burning, and heavily shorted. Do your own research or consult a licensed adviser. Past performance is not indicative of future results. Intellia is coiling, not breaking out. At about $12.12 the stock is pinned on the 50-day moving average near $12 and still under the 200-day near $12.84. It is roughly 57 percent below the 52-week high of $28.25 and about 52 percent above the...